Related Experiment Video
Updated: Jun 10, 2026

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
Targeting abnormal DNA double strand break repair in cancer
Feyruz V Rassool1, Alan E Tomkinson
1Department of Radiation Oncology, Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, 655 West Baltimore Street, Baltimore, MD 21201, USA.
Abstract:
A major challenge in cancer treatment is the development of therapies that target cancer cells with little or no toxicity to normal tissues and cells. Alterations in DNA double strand break (DSB) repair in cancer cells include both elevated and reduced levels of key repair proteins and changes in the relative contributions of the various DSB repair pathways. These differences can result in increased sensitivity to DSB-inducing agents and increased genomic instability. The development of agents that selectively inhibit the DSB repair pathways that cancer cells are more dependent upon will facilitate the design of therapeutic strategies that exploit the differences in DSB repair between normal and cancer cells. Here, we discuss the pathways of DSB repair, alterations in DSB repair in cancer, inhibitors of DSB repair and future directions for cancer therapies that target DSB repair.
Insights
Targeting DNA double-strand break (DSB) repair in cancer offers new therapeutic strategies. Exploiting cancer cells
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Developing cancer therapies with minimal toxicity to normal cells remains a significant challenge.
- Cancer cells exhibit altered DNA double-strand break (DSB) repair mechanisms, including changes in repair protein levels and pathway utilization.
- These alterations can lead to increased genomic instability and heightened sensitivity to DNA-damaging agents.
Purpose of the Study:
- To discuss the various pathways involved in DNA double-strand break (DSB) repair.
- To review the alterations in DSB repair observed in cancer cells.
- To explore the potential of targeting DSB repair pathways for novel cancer therapies.
Main Methods:
- Review of existing literature on DNA double-strand break (DSB) repair pathways.
- Analysis of alterations in DSB repair mechanisms in the context of cancer.
- Discussion of inhibitors targeting DSB repair pathways.
Main Results:
- Cancer cells display distinct alterations in DNA double-strand break (DSB) repair pathways compared to normal cells.
- These differences present opportunities for developing targeted cancer treatments.
- Inhibitors of specific DSB repair pathways can selectively target cancer cells.
Conclusions:
- Targeting DNA double-strand break (DSB) repair pathways is a promising strategy for cancer therapy.
- Exploiting the differential DSB repair mechanisms between cancer and normal cells can enhance treatment efficacy and reduce toxicity.
- Further research into DSB repair inhibitors and their clinical application is warranted.
Related Concept Videos
Fixing Double-strand Breaks
Fixing Double-strand Breaks
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...

